Clinical Trial Update: Autologous Muscle Derived Cells for Female Urinary Sphincter Repair [Phase 3]

View source ↗

Summary

Phase 3 trial of autologous muscle-derived cells for female urinary sphincter repair completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Autologous Muscle Derived Cells (autologous muscle-derived cells)

Snippet

Sponsor: Cook MyoSite | Conditions: Stress Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2023-01-05